Cargando…
Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer
Despite the clinical outcomes being extremely limited, blocking immune inhibitory checkpoint pathways has been in the spotlight as a promising strategy for treating gastrointestinal cancer. However, a distinct strategy for the successful treatment is obviously needed in the clinical settings. Myeloi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539086/ https://www.ncbi.nlm.nih.gov/pubmed/36211375 http://dx.doi.org/10.3389/fimmu.2022.1009701 |